Natini Jinawath

7PUBLICATIONS
31CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Liquid biopsiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 17, 2025
EPHX1 and ERCC2 polymorphisms are associated with cisplatin-induced nephrotoxicity and prognosis in Thai cancer patients.

Saad Ahmed, Jakris Eu-Ahsunthornwattana, Thanaporn Thamrongjirapat

|Jan 23, 2025
RNAscope Multiplex FISH Signal Assessment in FFPE and Fresh Frozen Tissues: The Effect of Archival Duration on RNA Expression.

Ariestya Indah Permata Sari, Katherine Copeland, Pattarin Nuwongsri

|May 11, 2024
Extracellular Vesicles for Childhood Cancer Liquid Biopsy.

Nilubon Singhto, Pongpak Pongphitcha, Natini Jinawath

|Nov 20, 2023
A Phase I Study of the CDK4/6 Inhibitor Palbociclib in Combination with Cetuximab and Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.

Nuttapong Ngamphaiboon, Poompis Pattaranutaporn, Somthawin Lukerak

|May 10, 2023
Six-MicroRNA Prognostic Signature in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma.

Wittawin Worakitchanon, Wittaya Panvongsa, Teerada Siripoon

Pageof 2